TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages-Reference-Cited by-同舟云学术

TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages

Published:2013-03-22 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Yuan Bao-Zhu,Chapman Joshua,Ding Min,Wang Junzhi,Jiang Binghua,Rojanasakul Yon,Reynolds Steven H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-140.pdf

Reference41 articles.

1. Antman KH: Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol. 1981, 8: 313-320.

2. Price B: Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997, 145: 211-218. 10.1093/oxfordjournals.aje.a009093.

3. Goudar RK: New therapeutic options for mesothelioma. Curr Oncol Rep. 2005, 7: 260-265. 10.1007/s11912-005-0048-3.

4. Krug LM: An overview of chemotherapy for mesothelioma. Hematol Oncol Clin North Am. 2005, 19: 1117-1136. 10.1016/j.hoc.2005.09.010. vii

5. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003, 21: 2636-2644. 10.1200/JCO.2003.11.136.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells;Hematological Oncology;2022-07-14

2. Emerging Potential Agents against Malignant Pleural Mesothelioma: A Review of in vitro Studies;Gazi Medical Journal;2019-04-01

3. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway;Oxidative Medicine and Cellular Longevity;2019-03-25

4. A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma;American Journal of Clinical Oncology;2018-10

5. NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy;Advanced Healthcare Materials;2018-03-12